The CRAFITY score to predict hepatocellular carcinoma disease control rate at month 12 in patients undergoing transarterial chemoembolization

被引：0
|
作者：
Veelken, Rhea [1 ]
Olbrich, Anne [1 ]
Lieb, Sabine [1 ]
Schindler, Aaron [1 ]
Herber, Adam [1 ]
Ebel, Sebastian [2 ]
Denecke, Timm [2 ]
Berg, Thomas [1 ]
van Bommel, Florian [1 ]
机构：
[1] Univ Hosp Leipzig, Div Hepatol, Dept Med 2, Leipzig, Germany
[2] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-501-YI
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [1] CRAFITY score benefits hepatocellular carcinoma patients treated with transarterial chemoembolization and lenvatinib
    Zhang, Lin
    Yang, Hongcai
    Ning, Shangkun
    Wu, Zhijuan
    Wang, Dianzhe
    Liang, Hexin
    Wang, Chunni
    Chang, Xu
    CANCER MEDICINE, 2024, 13 (12):
  • [2] CRAFITY score is associated with overall survival in patients with hepatocellular carcinoma treated with transarterial chemoembolisation
    Veelken, Rhea
    Olbrich, Anne
    Schindler, Aaron
    Lieb, Sabine
    Fischer, Janett
    Ebel, Sebastian
    Denecke, Timm
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2023, 78 : S507 - S507
  • [3] Predictors of Mortality in Patients with Hepatocellular Carcinoma undergoing Transarterial Chemoembolization
    Barman, Pranab
    Sharma, Pratima
    Krishnamurthy, Venkat
    Willatt, Jonathon
    McCurdy, Heather
    Moseley, Richard H.
    Su, Grace L.
    HEPATOLOGY, 2013, 58 : 1271A - 1271A
  • [4] Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Barman, Pranab M.
    Sharma, Pratima
    Krishnamurthy, Venkat
    Willatt, Jonathon
    McCurdy, Heather
    Moseley, Richard H.
    Su, Grace L.
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (11) : 2821 - 2825
  • [5] Predictors of Mortality in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Pranab M. Barman
    Pratima Sharma
    Venkat Krishnamurthy
    Jonathon Willatt
    Heather McCurdy
    Richard H. Moseley
    Grace L. Su
    Digestive Diseases and Sciences, 2014, 59 : 2821 - 2825
  • [6] Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Ho, Shu-Yein
    Liu, Po-Hong
    Hsu, Chia-Yang
    Ko, Chih-Chieh
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lee, Rheun-Chuan
    Tsai, Ping-Hsing
    Hou, Ming-Chih
    Huo, Teh-Ia
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3196 - 3203
  • [7] TUMOR BURDEN SCORE AS A NEW PROGNOSTIC MARKER FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING TRANSARTERIAL CHEMOEMBOLIZATION
    Ho, Shu-Yein
    Ko, Chih-Chieh
    Su, Chien-Wei
    Huo, Teh-Ia
    GUT, 2021, 70 : A75 - A76
  • [8] NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization
    Adhoute, Xavier
    Penaranda, Guillaume
    Raoul, Jean Luc
    Bollon, Emilie
    Pol, Bernard
    Letreut, Yves P.
    Perrier, Herve
    Bayle, Olivier
    Monnet, Olivier
    Beaurain, Patrick
    Muller, Cyril
    Hardwigsen, Jean
    Lefolgoc, Gaelle
    Castellani, Paul
    Bronowicki, Jean P.
    Bourliere, Marc
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (06) : 706 - 715
  • [9] Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Yossi Ventura
    Brian I Carr
    Issac Kori
    Vito Guerra
    Oren Shibolet
    World Journal of Gastroenterology, 2018, (15) : 1641 - 1649
  • [10] Transarterial chemoembolization for patients with hepatocellular carcinoma
    Forner, Alejandro
    Real, M. Isabel
    Varela, Maria
    Bruix, Jordi
    HEPATOLOGY RESEARCH, 2007, 37 : S230 - S237
12345